Journal Club 6/15/23 - Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of C. diff Infection
On Thursday, June 15th at our monthly Infectious Diseases Journal Club, Dr. Swetha Srialluri led discussion on this study looking at real-world use of bezlotoxumab and fecal microbiota transplantation for treatment of Clostridioides difficile infection.
We compared the results of this study to those from RCTs for bezlotoxumab and oral FMT, and discussed the roles of each of these therapies in management of CDI patients at high-risk for recurrences and those who have had multiple recurrences. We also discussed cost considerations and implementation of these interventions.
Comments
Post a Comment